Novel dihydropyrimidines as a potential new class of antitubercular agents

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

A small library of 30 dihydropyrimidines was synthesized and evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H(37)Rv. Two compounds, ethyl 4-[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5 carboxylate 4a and ethyl 4-[3-(4-nitrophenyl)-1-phenyl-1H-pyrazol-4-yl]-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 4d were found to be the most active compounds in vitro with MIC of 0.02 μg/mL against MTB and were more potent than isoniazid.

Knowledge Graph

Similar Paper

Novel dihydropyrimidines as a potential new class of antitubercular agents
Bioorganic & Medicinal Chemistry Letters 2010.0
4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of Antimycobacterium tuberculosis agents
European Journal of Medicinal Chemistry 2010.0
Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues
Bioorganic & Medicinal Chemistry Letters 2011.0
Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues
Bioorganic & Medicinal Chemistry Letters 2012.0
Synthesis and antimycobacterial evaluation of 3a,4-dihydro-3H-indeno [1,2-c] pyrazole-2-carboxamide analogues
European Journal of Medicinal Chemistry 2011.0
Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea
Bioorganic & Medicinal Chemistry Letters 2006.0
Preparation, biological evaluation and molecular docking study of imidazolyl dihydropyrimidines as potential Mycobacterium tuberculosis dihydrofolate reductase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides
European Journal of Medicinal Chemistry 2009.0